These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16266359)

  • 1. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
    Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
    Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy.
    Barbano RL; Herrmann DN; Hart-Gouleau S; Pennella-Vaughan J; Lodewick PA; Dworkin RH
    Arch Neurol; 2004 Jun; 61(6):914-8. PubMed ID: 15210530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
    Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
    Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.
    Herrmann DN; Pannoni V; Barbano RL; Pennella-Vaughan J; Dworkin RH
    Muscle Nerve; 2006 Jan; 33(1):42-8. PubMed ID: 16228968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.
    Gammaitoni AR; Galer BS; Onawola R; Jensen MP; Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S13-9. PubMed ID: 15563742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical pain management with the 5% lidocaine medicated plaster--a review.
    Mick G; Correa-Illanes G
    Curr Med Res Opin; 2012 Jun; 28(6):937-51. PubMed ID: 22551228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
    Simpson DM; Estanislao L; Brown SJ; Sampson J
    J Pain Symptom Manage; 2008 Mar; 35(3):299-306. PubMed ID: 17959343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.
    Galer BS; Gammaitoni AR; Oleka N; Jensen MP; Argoff CE
    Curr Med Res Opin; 2004; 20 Suppl 2():S5-12. PubMed ID: 15563741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study.
    Nalamachu S; Crockett RS; Mathur D
    J Fam Pract; 2006 Mar; 55(3):209-14. PubMed ID: 16510054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
    Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
    Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis.
    Galer BS; Sheldon E; Patel N; Codding C; Burch F; Gammaitoni AR
    Curr Med Res Opin; 2004 Sep; 20(9):1455-8. PubMed ID: 15383194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.
    Ho KY; Huh BK; White WD; Yeh CC; Miller EJ
    Clin J Pain; 2008 Jan; 24(1):51-5. PubMed ID: 18180637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
    Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
    Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient perceptions associated with the 5% lidocaine medicated plaster in daily practice.
    Überall MA; Müller-Schwefe GH
    Curr Med Res Opin; 2012 Jun; 28(6):901-9. PubMed ID: 22506624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom profiles differ in patients with neuropathic versus non-neuropathic pain.
    Dworkin RH; Jensen MP; Gammaitoni AR; Olaleye DO; Galer BS
    J Pain; 2007 Feb; 8(2):118-26. PubMed ID: 16949878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.
    Katz NP; Gammaitoni AR; Davis MW; Dworkin RH;
    Pain Med; 2002 Dec; 3(4):324-32. PubMed ID: 15099237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.